Published in J Gen Intern Med on January 01, 2005
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial. J Consult Clin Psychol (2008) 1.33
Joint effect of cigarette smoking and alcohol consumption on mortality. Prev Med (2007) 1.16
The combined effect of smoking tobacco and drinking alcohol on cause-specific mortality: a 30 year cohort study. BMC Public Health (2010) 1.01
Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl) (2014) 0.95
Quitting smoking and change in alcohol consumption in the International Tobacco Control (ITC) Four Country Survey. Drug Alcohol Depend (2010) 0.88
Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. Am J Drug Alcohol Abuse (2014) 0.85
Effects of cigarette smoking, metabolic syndrome and dehydroepiandrosterone deficiency on intima-media thickness and endothelial function in hypertensive postmenopausal women. Med Sci Monit (2012) 0.85
Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart (2014) 0.81
Relationships between Diet, Alcohol Preference, and Heart Disease and Type 2 Diabetes among Americans. PLoS One (2015) 0.79
Alcohol and cardio-respiratory deaths in Chinese: a population-based case-control study of 32,462 older Hong Kong adults. BMC Public Health (2009) 0.79
Problem drinkers: find them, keep them, don't lose them-treat them--treat them. J Gen Intern Med (2005) 0.78
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs (2015) 0.77
Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacol Biochem Behav (2015) 0.77
Cardiovascular risk behavior among sedentary female smokers and smoking cessation outcomes. Tob Induc Dis (2005) 0.77
Potential contribution of aspirin to cancer control programmes. Ecancermedicalscience (2008) 0.75
A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy Drinking Smokers Seeking Smoking Cessation Treatment. Alcohol Clin Exp Res (2017) 0.75
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Alcohol and mortality in British men: explaining the U-shaped curve. Lancet (1988) 5.34
The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14
Alcohol and coronary heart disease: a meta-analysis. Addiction (2000) 3.72
A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med (1988) 3.33
Alcohol and mortality: a U-shaped curve. Lancet (1981) 3.28
Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med (1977) 2.98
Moderate alcohol consumption and the risk of breast cancer. N Engl J Med (1987) 2.58
Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med (2000) 2.57
Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev (1993) 2.54
Alcohol and mortality. Ann Intern Med (1992) 2.49
Alcohol and mortality. A ten-year Kaiser-Permanente experience. Ann Intern Med (1981) 2.48
Physical activity and mortality in postmenopausal women. JAMA (1997) 2.45
Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies. Circulation (1977) 2.44
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. BMJ (1994) 2.31
Dietary assessment of older Iowa women with a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol (1992) 2.28
Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) (1986) 2.22
Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol (1986) 2.07
Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol (1994) 2.06
Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol (1990) 1.90
Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol (1990) 1.88
Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol (1987) 1.81
Stability of alcohol consumption over time: evidence from three longitudinal surveys from the United States. J Stud Alcohol (2002) 1.68
Alcohol consumption and mortality in Alameda County. J Chronic Dis (1987) 1.59
Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med (1997) 1.58
Moderate alcohol intake is associated with survival in the elderly: the Dubbo Study. Med J Aust (2000) 1.55
Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J (1985) 1.40
Alcohol and heart disease. Circulation (1996) 1.39
Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol (2001) 1.32
Alcohol consumption and sudden coronary death in middle-aged Finnish men. Acta Med Scand (1987) 1.31
Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol (1983) 1.27
Alcohol and mortality in the Italian rural cohorts of the Seven Countries Study. Int J Epidemiol (1992) 1.26
Alcohol and mortality in Busselton, Western Australia. Am J Epidemiol (1993) 1.25
Alcohol and mortality in the Busselton study. Int J Epidemiol (1982) 1.19
Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation (1980) 1.11
Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study. J Stud Alcohol (1992) 1.11
Drinking habits and coronary heart disease: the Yugoslavia cardiovascular disease study. Am J Epidemiol (1982) 1.11
DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med (2003) 1.10
Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25-42 years of age. Cancer Epidemiol Biomarkers Prev (1999) 1.09
Major risk factors for cardiovascular disease mortality in adults: results from the Nutrition Canada Survey cohort. Int J Epidemiol (1988) 1.09
The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis (1997) 1.07
Drinking and mortality. The Albany Study. Am J Epidemiol (1987) 1.06
Alcohol and coronary heart disease. Int J Epidemiol (2001) 1.05
Alcohol consumption and risk of breast cancer: a cohort study. Cancer Causes Control (2000) 1.04
Light to moderate alcohol consumption and mortality in the elderly. J Am Geriatr Soc (1992) 1.00
Platelet aggregation induced by ADP or epinephrine is enhanced in habitual smokers. Thromb Res (2000) 0.95
Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen Study. Am J Epidemiol (1984) 0.94
Intake of spirits and beer and risk of myocardial infarction and death--a longitudinal study in Eastern Finland. J Chronic Dis (1983) 0.93
Alcohol consumption and risk of ischemic heart disease in women. Arch Intern Med (1993) 0.92
Misclassification and under-reporting of acute myocardial infarction by elderly persons: implications for community-based observational studies and clinical trials. J Clin Epidemiol (1999) 0.92
Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control (2001) 0.90
Alcohol and breast cancer mortality in a cohort study. Breast Cancer Res Treat (2000) 0.88
Alcohol consumption: protection against coronary heart disease and risks to health. Int J Epidemiol (1990) 0.87
A prospective study of the development of coronary heart disease in a group of 1202 middle-aged men. J Epidemiol Community Health (1980) 0.86
Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin (2001) 0.84
The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol (1997) 0.84
Alcohol and breast cancer: a cohort study. Prev Med (1988) 0.84
Alcohol consumption and mortality in aging or aged Finnish men. J Clin Epidemiol (1989) 0.84
Commentary: alcohol, coronary heart disease and public health: which evidence-based policy. Int J Epidemiol (2001) 0.83
Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med (1991) 0.82
Cigarette smoking, blood pressure and serum lipids and lipoproteins in middle-aged women. J Physiol Anthropol Appl Human Sci (2001) 0.82
Patient-directed, nonprescription approaches to cardiovascular disease. Arch Intern Med (1994) 0.81
The relationship between alcohol and mortality among Japanese physicians. Int J Epidemiol (1983) 0.76
Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A (2012) 7.14
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 5.43
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 5.05
Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J (2009) 4.90
Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol (2008) 4.83
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med (2004) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Physical activity and stroke risk: a meta-analysis. Stroke (2003) 4.19
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. Arch Intern Med (2007) 4.05
Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care (2005) 3.96
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol (2003) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med (2006) 3.33
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet (2011) 3.07
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era. J Clin Oncol (2009) 3.07
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2005) 3.00
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol (2004) 3.00
Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol (2009) 2.95
Functional limitations in elderly female cancer survivors. J Natl Cancer Inst (2006) 2.89
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study. Am J Hematol (2009) 2.84
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 2.82
Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 2.81
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.76
Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med (2005) 2.67
Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000. Am J Epidemiol (2004) 2.59
Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet (2009) 2.58
Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res (2007) 2.56
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol (2004) 2.46
Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2002) 2.43
Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2003) 2.41
Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood (2002) 2.41
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol (2006) 2.38
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke (2006) 2.33
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood (2010) 2.21
Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008. Circulation (2012) 2.20
Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol (2008) 2.19
A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol (2011) 2.19
Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev (2004) 2.19
The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc (2013) 2.18
Epidemiology of ovarian cancer. Methods Mol Biol (2009) 2.18
Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst (2004) 2.17
The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med (2006) 2.10
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol (2005) 2.09
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood (2009) 2.07